Page 152 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 152
Chapter 9 Hematopoietic Stem Cell Biology 110.e13
543. Mullighan CG, Downing JR: Genome-wide profiling of genetic 547. Beerman I, Rossi DJ: Epigenetic Control of Stem Cell Potential during
alterations in acute lymphoblastic leukemia: recent insights and future Homeostasis, Aging, and Disease. Cell Stem Cell 16:613–625, 2015.
directions. Leukemia 23:1209–1218, 2009. doi: 10.1038/leu.2009.18. doi: 10.1016/j.stem.2015.05.009.
544. Glass C, Wilson M, Gonzalez R, et al: The role of EVI1 in myeloid 548. Solary E, Bernard OA, Tefferi A, et al: The Ten-Eleven Translocation-2
malignancies. Blood Cells Mol Dis 53:67–76, 2014. doi: 10.1016/j. (TET2) gene in hematopoiesis and hematopoietic diseases. Leukemia
bcmd.2014.01.002. 28:485–496, 2014. doi: 10.1038/leu.2013.337.
545. Rao RC, Dou Y: Hijacked in cancer: the KMT2 (MLL) family of 549. Abdel-Wahab O, et al: Deletion of Asxl1 results in myelodysplasia and
methyltransferases. Nat Rev Cancer 15:334–346, 2015. doi: 10.1038/ severe developmental defects in vivo. J Exp Med 210:2641–2659, 2013.
nrc3929. doi: 10.1084/jem.20131141.
546. Chen CW, Armstrong SA: Targeting DOT1L and HOX gene expression 550. Itzykson R, Fenaux P: Epigenetics of myelodysplastic syndromes.
in MLL-rearranged leukemia and beyond. Exp Hematol 43:673–684, Leukemia 28:497–506, 2014. doi: 10.1038/leu.2013.343.
2015. doi: 10.1016/j.exphem.2015.05.012.
